PGC‐1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI

Citations Over TimeTop 10% of 2019 papers

Abstract

PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1α, PPARGC1A) regulates the expression of genes involved in energy homeostasis and mitochondrial biogenesis. Here we identify inactivation of the transcriptional regulator PGC-1α as a landmark for experimental nephrotoxic acute kidney injury (AKI) and describe the in vivo consequences of PGC-1α deficiency over inflammation and cell death in kidney injury. Kidney transcriptomic analyses of WT mice with folic acid-induced AKI revealed 1398 up- and 1627 downregulated genes. Upstream transcriptional regulator analyses pointed to PGC-1α as the transcription factor potentially driving the observed expression changes with the highest reduction in activity. Reduced PGC-1α expression was shared by human kidney injury. Ppargc1a-/- mice had spontaneous subclinical kidney injury characterized by tubulointerstitial inflammation and increased Ngal expression. Upon AKI, Ppargc1a-/- mice had lower survival and more severe loss of renal function, tubular injury, and reduction in expression of mitochondrial PGC-1α-dependent genes in the kidney, and an earlier decrease in mitochondrial mass than WT mice. Additionally, surviving Ppargc1a-/- mice showed higher rates of tubular cell death, compensatory proliferation, expression of proinflammatory cytokines, NF-κB activation, and interstitial inflammatory cell infiltration. Specifically, Ppargc1a-/- mice displayed increased M1 and decreased M2 responses and expression of the anti-inflammatory cytokine IL-10. In cultured renal tubular cells, PGC-1α targeting promoted spontaneous cell death and proinflammatory responses. In conclusion, PGC-1α inactivation is a key driver of the gene expression response in nephrotoxic AKI and PGC-1α deficiency promotes a spontaneous inflammatory kidney response that is magnified during AKI. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Related Papers

• → Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis(2000)1,264 cited
• → The hitchhiker’s guide to PGC-1α isoform structure and biological functions(2015)203 cited
• → Mitochondrial Biogenesis Inhibitors for Anticancer Therapy: A Review of Recent Patents(2016)4 cited
• → Peroxisome proliferator–activated receptor- γ coactivator 1α (PPARGC1A; PGC-1α); twist homolog 1 (TWIST1)(2009)1 cited
• → Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Alpha Isoform 4(2020)